DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gland Pharma Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·8 Sept 2026, 2:15 pm

Gland Pharma

Gland Pharma has announced that it will host a meeting with analysts and institutional investors. This event is scheduled to take place in the coming days and is part of the company's standard practice to engage with the investment community.

For investors, this update signals that the company is preparing to discuss its business performance and future outlook. Such meetings often provide insights into management's perspective, which can be valuable for those tracking the stock's trajectory.

Investors should watch for any specific guidance or commentary regarding operational metrics or strategic plans shared during the interaction.